Hurtig H - Search Results

1

Olfactory function in Parkinson's disease subtypes.

Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H. Stern MB, et al. Among authors: hurtig h. Neurology. 1994 Feb;44(2):266-8. doi: 10.1212/wnl.44.2.266. Neurology. 1994. PMID: 8309571

2

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients.

Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, Gollomp S, Stolley P. Stern M, et al. Among authors: hurtig h. Arch Neurol. 1991 Sep;48(9):903-7. doi: 10.1001/archneur.1991.00530210029018. Arch Neurol. 1991. PMID: 1953412

3

Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease.

Hurtig H, Joyce J, Sladek JR Jr, Trojanowski JQ. Hurtig H, et al. Ann Neurol. 1989 Jun;25(6):607-14. doi: 10.1002/ana.410250613. Ann Neurol. 1989. PMID: 2742361

4

Treatment of organic bipolar mood disorders in Parkinson's disease.

Kim E, Zwil AS, McAllister TW, Glosser DS, Stern M, Hurtig H. Kim E, et al. Among authors: hurtig h. J Neuropsychiatry Clin Neurosci. 1994 Spring;6(2):181-4. doi: 10.1176/jnp.6.2.181. J Neuropsychiatry Clin Neurosci. 1994. PMID: 8044042

5

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.

Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J, et al. Olanow CW, et al. Among authors: hurtig h. Mov Disord. 1994 Jan;9(1):40-7. doi: 10.1002/mds.870090107. Mov Disord. 1994. PMID: 8139604 Clinical Trial.

6

Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.

Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Siderowf A, et al. Among authors: hurtig h. Mov Disord. 2006 Jun;21(6):746-53. doi: 10.1002/mds.20786. Mov Disord. 2006. PMID: 16463342 Clinical Trial.

7

Association between cognition and function in patients with Parkinson disease with and without dementia.

Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A. Rosenthal E, et al. Among authors: hurtig h. Mov Disord. 2010 Jul 15;25(9):1170-6. doi: 10.1002/mds.23073. Mov Disord. 2010. PMID: 20310053 Free PMC article.

8

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C. Siderowf A, et al. Among authors: hurtig h. Neurology. 2010 Sep 21;75(12):1055-61. doi: 10.1212/WNL.0b013e3181f39a78. Epub 2010 Aug 18. Neurology. 2010. PMID: 20720189 Free PMC article.

9

A recommended scale for cognitive screening in clinical trials of Parkinson's disease.

Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY; Parkinson Study Group Cognitive/Psychiatric Working Group. Chou KL, et al. Mov Disord. 2010 Nov 15;25(15):2501-7. doi: 10.1002/mds.23362. Mov Disord. 2010. PMID: 20878991 Free PMC article.

10

Parkinson's disease mild cognitive impairment: application and validation of the criteria.

Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I; MDS Study Group on the Validation of PD-MCI Criteria. Geurtsen GJ, et al. J Parkinsons Dis. 2014;4(2):131-7. doi: 10.3233/JPD-130304. J Parkinsons Dis. 2014. PMID: 24296865 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page